Determination of Antibacterial Efficacy of Lactoferrin Glycoprotein Obtained from Cow Colostrum

Year 2023, , 27 - 34, 27.12.2023

İlhan Sabancılar , Gülten Toprak Hakan Temiz

https://doi.org/10.56484/iamr.1326284

Abstract

Objective: It was aimed to investigate the antibacterial effect levels of Lactoferrin protein in cow colostrum. The aim of the study was to evaluate the effect of lactoferrin protein obtained from a natural product on the growth of Escherichia coli, Pseudomonas aerugenosa and Staphylococcus aureus.
Method: Lactoferrin at 4 different concentrations (100 mg/ml, 50 mg/ml, 25mg/ml and 12.5mg/ml) was impregnated on 6 mm discs prepared from filter paper and placed on the MHA plate and after incubation at 37˚C for 24 hours, inhibition was evaluated. The antibacterial effect levels of naturally obtained lactoferrin at different concentrations were compared.
Results: It was determined that the antibacterial activity of lactoferrin against Gram-negative bacteria Pseudomonas aeruginosa was higher than the other bacterial species in the study. It was determined that Lactoferrin at a concentration of 12.5mg/ml had the least inhibitory effect in the studied bacteria. It was concluded that E.coli and S. aureus were bacteria resistant to the antibacterial activity of lactoferrin.
Conclusion: It was observed that this effect was limited in E.coli bacteria. In the light of these results, it was concluded that Lactoferrin, an antibacterial agent, has different antibacterial effects depending on the bacterial species and dose.

Keywords

Cow colostrum, lactoferrin, antibacterial effect and whey protein.

Project Number

TIP 20.029.

References

• Soerensen M, Soerensen SPL. Proteins in whey. CR Trav. Lab. Carlsberg. 1940; 23 (7): 55-99.
• Johansson B. Isolation of iron-containing red protein from human milk. Açta Chem. Scand. 1960; 14:510-512. doi: 10.3891 / acta.chem.scand.14-0510.
• Christiansen S, Guo M and Kjelden D. Chemical composition and nutrient profile of low molecular weight fraction of bovine colostrum. Int. Dairy J 2010; 20, 630–636. DOI:10.1016/j.idairyj.2009.12.005
• Godhia ML and Patel N. Colostrum İts composition, benefits as a nutraceutical: a review. Current Res. Nutr. Food Sci. 2013; 1:37-47. DOI:10.12944/crnfsj.1.1.04
• Kelly GS. Bovine colostrum: a review of clinical uses. Altern. Med. Rev. 2003; 8:378-394.
• McGrath BA, Fox PF, McSweeney PLH and Kelly AL. Composition and properties of bovine colostrum: a review. Dairy Sci. And Technol. 2016; 96:133-158. DOI 10.1007/s13594-015-0258-x.
• Gonzalez-Chavez SA, Arevalo-Gallego S, Rascon-Cruz Q. Lactoferrin: structure, function and applications. International Journal of Antimicrobial Agents 2009; 33:301-309.
• Sahana N, Ramasamy D, Pugazhenthi TR and Manikkavasagan I. Studies on physical and microbial parameters of bovine colostrum powder. Int. J. Curr. Microbiol. App. Sci.7, 2018: 2766- 2771. DOI:10.20546/ijcmas.2018.708.290
• Korohnen H. Colostrum immunoglobulins andthe complement system-potential ingredients offunctional foods. Bulletin Inter. Dairy Federation, Brussels. 1998: 36-40.
• 1Baveye S, Elass E, Mazurier J, Spik G, Legrand D. (Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med. 1999; 37:281-286. doi: 10.1515 / CCLM.1999.049
• Seifu E, Buys EM and Donkin EF. Signifcance of the lactoperoxidase system in the dairy industry and its potential applications: a review. Trends Food Sci. Technol. 16, 2005: 137- 154 https://doi.org/10.1016/j.tifs.2004.11.002
• Ammons M and Copié V. Mini-review: lactoferrin: a bioinspired, anti-bioflm therapeutic. Biofouling. 2013; 29:443-455.
• Gonzalez-Chavez SA, Arévalo-Gallegos S. and Rascón-Cruz Q. Lactoferrin: structure, function and applications. Int. J. of Antimicrob. Agents, 2009; 33:301-308. https://doi.org/10.1016/j.ijantimicag.2008.07.02
• Farnaud S, Evans RW. Lactoferrin: a multifunctional protein with antimicrobial properties. Molecular Immunology. 2003; 40:395–405.
• Jones EM, Smart A, Bloomberg G, Burgess L, Millar MR. Lactoferricin, a new antimicrobial peptide. Journal of Applied Microbiology. 1994; 77:208-214.
• Matijasic BB, Oberckal J, Lorbeg PM, Paveljsek D, Skale N, Kolenc B, Gruden S, Ulrih NP, Kete M, Justin MZ. Characterisation of lactoferrin isolated from acidwhey using pilot-scale monolithic ion-exchangechromatography Processes. 2020; 8(7):804-811. https://doi.org/10.3390/pr8070804.
• Farnaud S, Evans RW. Lactoferrin: amultifunctional protein with antimicrobialproperties. Molecular Immunology. 2003; 40:395–405.
• Plaut AG, Qiu J, St Geme JW. Humanlactoferrin proteolitic activity: analysis of thecleaved region in the IgA protease of Haemophilusinfluenzae. Vaccine 2000; 8:148–152.
• Longhi C, Conte MP, Seganti L et al. Influence of lactoferrin on the entry process ofEscherichia coli HB101 (pRI203) in HeLa cells.Medical Microbiology and Immunology (Berl). 1993; 182:25–35.
• Van der Kraan, MIA, Groenink J, Nazmi K, Veerman ECI, Bolscher JGM, Nieuw Amerongen AV. Lactoferrampin: a novelantimicrobial peptide in the N1-domain of bovinelactoferrin. Peptides. 2004; 25:177–183.